Cell & Gene Therapy: Current Landscape, Lessons Learned and Paths Forward

• Where have we come over the past 5 years
• What are the approvals and approval activity over the past year?
• What are the challenges and issues?
• What have we learned?
• What are the real important technologies that are being developed that might help transform the cell and gene therapy space
• What are the key things we need to think about moving forward?

Michael Kalos, PhD, Managing Director, Next Pillar Consulting

Learn more about the IO360° Summit at www.io360summit.com